Totals
- Total revenue
- $318,794
- Total expenses
- $369,802
- Contributions and grants received
- $278,868
- Grants paid
- $81,660
- Program service revenue
- $28,852
- Investment income
- $0
- Other revenue
- $11,074
- Total assets, end of year
- $432,360
- Total liabilities, end of year
- $5,616
- Net assets or fund balances, end of year
- $426,744
- Program services expenses (Part IX)
- $276,430
- Management and general expenses
- $40,669
- Fundraising expenses
- $52,703
- Program service expenses (Part III)
- $276,430
Program services were 74.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$113,565
-
1f · All other contributions, gifts and grants
$165,303
-
2a · Program service revenue: SCIENTIFIC CONFERENCE
total $28,852 · related or exempt $28,852
-
8a · Fundraising events: gross income
$32,456
-
8a · Fundraising events: contributions included on line 1c
$113,565
-
8b · Fundraising events: direct expenses
$21,382
-
8c · Net income from fundraising events
total $11,074 · excluded $11,074
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $81,660 · program services $81,660
-
7 · Other salaries and wages
total $64,146 · program services $59,331 · fundraising $4,815
-
9 · Other employee benefits
total $1,029 · program services $1,029
-
10 · Payroll taxes
total $8,001 · program services $7,464 · fundraising $537
-
11a · Fees: management
total $25,788 · management and general $25,788
-
11b · Fees: legal
total $1,050 · management and general $1,050
-
11c · Fees: accounting
total $3,561 · management and general $3,561
-
11e · Fees: professional fundraising services
total $45,000 · fundraising $45,000
-
11g · Fees: other
total $54,114 · program services $54,114
-
12 · Advertising and promotion
total $2,247 · management and general $2,247
-
13 · Office expenses
total $4,037 · program services $412 · management and general $3,121 · fundraising $504
-
14 · Information technology
total $5,335 · program services $3,138 · management and general $443 · fundraising $1,754
-
17 · Travel
total $8,986 · program services $8,986
-
19 · Conferences, conventions and meetings
total $54,793 · program services $54,793
-
23 · Insurance
total $3,455 · program services $271 · management and general $3,144 · fundraising $40
-
24a · Other expenses: PROGRAM EQUIPMENT AND M
total $3,988 · program services $3,988
-
24b · Other expenses: OTHER PAYROLL EXPENSES
total $1,116 · program services $892 · management and general $172 · fundraising $52
-
24c · Other expenses: BANK FEES & SERVICE CHA
total $1,094 · management and general $1,093 · fundraising $1
-
24d · Other expenses: MEMBERSHIPS
total $350 · program services $300 · management and general $50
-
24e · All other expenses
total $52 · program services $52
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $475,504 · end of year $411,385
-
4 · Accounts receivable
beginning of year $9,463 · end of year $20,925
-
9 · Prepaid expenses and deferred charges
beginning of year $4,000
-
15 · Other assets
beginning of year $0 · end of year $50
-
17 · Accounts payable and accrued expenses
beginning of year $799 · end of year $4,613
-
19 · Deferred revenue
beginning of year $10,416
-
25 · Other liabilities
beginning of year $0 · end of year $1,003
-
27 · Net assets without donor restrictions
beginning of year $265,648 · end of year $421,990
-
28 · Net assets with donor restrictions
beginning of year $212,104 · end of year $4,754
Mission and programs · 2024
Mission
Patient support and research for VCP Disease
-
Scientific and Clinical Trial Tools: Cure VCP Disease contracted with contract research groups to build a new patient registry and create two additional cell lines (isogenic controls to strength ongoing research)
Expenses $45,381
-
Sponsorship of Research: Nationwide Childrens. The purpose of this study is to learn about how VCP disease changes people's movement and strength overtime. Forty-six individuals participated to help prepare for future clinical trials.
Expenses $64,730 · Grants $64,730
-
Research Network and Conference: Facilitate the VCP research network and host scientific convenings to encourage collaboration. Our 2024 scientific conference brought together 100 scientists and patient advocates to share new research and plan future research
Expenses $130,573
-
Grants $16,930Conference $500Research $8,733Information Technology $3,138Office Expenses $412Educational resources $52Program Equip. & Mater. $3,988Membership $300Travel $1,693
Expenses $35,746 · Grants $16,930
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Nathan PeckNATHAN PECK
CEO
- Total calculated
- $0
- Hours/week
- 15
-
Allison PeckALLISON PECK
CFO
- Total calculated
- $0
- Hours/week
- 15
-
Amy CaseyAMY CASEY
SECRETARY
- Total calculated
- $0
- Hours/week
- 10
-
Kelly GoldKELLY GOLD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Sara BuhrSARA BUHR
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Maureen McArthur HartMAUREEN MCARTHUR HART
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
A 50-50 MATCHING GRANT TO A YOUNG INVESTIGATOR PURSING GENE EDITING
-
THE PURPOSE OF THE STUDY IS BIOMARKER DISCOVERY. CALTECH TESTED PATIENT'S BLOOD TO LOOK FOR DIFFERENCES TO SEE IF CHANGES CAN BE DETECTED IN RELATION TO DISEASE PROGRESSION
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 14 May 2025
- IRS schema version
- 2024v5.1
- Source object
- 202511349349305521
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.